Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Association between Vitamin D and Risk for Early and Late Post-Transplant Complications.

Bhandari R, Malvar J, Sacapano A, Aguayo-Hiraldo P, Jodele S, Orgel E.

Biol Blood Marrow Transplant. 2019 Oct 22. pii: S1083-8791(19)30668-8. doi: 10.1016/j.bbmt.2019.10.011. [Epub ahead of print]

PMID:
31654787
2.

Routine analytical method for monitoring the main metabolites for a recurrent group of parabens and pharmaceuticals in wastewater and tap water.

Malvar JL, Santos JL, Martín J, Aparicio I, Alonso E.

Anal Bioanal Chem. 2019 Oct;411(25):6625-6635. doi: 10.1007/s00216-019-02035-2. Epub 2019 Jul 27.

PMID:
31352502
3.

Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells.

Wu HW, Sheard MA, Malvar J, Fernandez GE, DeClerck YA, Blavier L, Shimada H, Theuer CP, Sposto R, Seeger RC.

Clin Cancer Res. 2019 Aug 1;25(15):4761-4774. doi: 10.1158/1078-0432.CCR-18-3358. Epub 2019 May 8.

4.

A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.

Thomas SM, Malvar J, Tran HH, Shows JT, Freyer DR.

Cancer. 2018 Oct 15;124(20):4064-4071. doi: 10.1002/cncr.31727. Epub 2018 Oct 6.

5.

Determination of perfluorinated compounds, bisphenol A, anionic surfactants and personal care products in digested sludge, compost and soil by liquid-chromatography-tandem mass spectrometry.

Abril C, Santos JL, Malvar JL, Martín J, Aparicio I, Alonso E.

J Chromatogr A. 2018 Nov 16;1576:34-41. doi: 10.1016/j.chroma.2018.09.028. Epub 2018 Sep 17.

PMID:
30266235
6.

Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma.

Barry WE, Jackson JR, Asuelime GE, Wu HW, Sun J, Wan Z, Malvar J, Sheard MA, Wang L, Seeger RC, Kim ES.

Clin Cancer Res. 2019 Jan 1;25(1):325-333. doi: 10.1158/1078-0432.CCR-18-1317. Epub 2018 Sep 19.

7.

Dispersive liquid-liquid microextraction as a new clean-up procedure for the determination of parabens, perfluorinated compounds, UV filters, biocides, surfactants, and plasticizers in root vegetables.

Abril C, Martín J, Malvar JL, Santos JL, Aparicio I, Alonso E.

Anal Bioanal Chem. 2018 Aug;410(21):5155-5163. doi: 10.1007/s00216-018-1165-9. Epub 2018 Jun 12.

PMID:
29947903
8.

The Use of Aromatherapy to Reduce Chemotherapy-Induced Nausea in Children With Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial.

Evans A, Malvar J, Garretson C, Pedroja Kolovos E, Baron Nelson M.

J Pediatr Oncol Nurs. 2018 Nov/Dec;35(6):392-398. doi: 10.1177/1043454218782133. Epub 2018 Jun 27.

PMID:
29947285
9.

Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study.

Sun W, Malvar J, Sposto R, Verma A, Wilkes JJ, Dennis R, Heym K, Laetsch TW, Widener M, Rheingold SR, Oesterheld J, Hijiya N, Sulis ML, Huynh V, Place AE, Bittencourt H, Hutchinson R, Messinger Y, Chang B, Matloub Y, Ziegler DS, Gardner R, Cooper T, Ceppi F, Hermiston M, Dalla-Pozza L, Schultz KR, Gaynon P, Wayne AS, Whitlock JA.

Leukemia. 2018 Nov;32(11):2316-2325. doi: 10.1038/s41375-018-0094-0. Epub 2018 Mar 15.

10.

Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes.

Webb MW, Sun J, Sheard MA, Liu WY, Wu HW, Jackson JR, Malvar J, Sposto R, Daniel D, Seeger RC.

Int J Cancer. 2018 Sep 15;143(6):1483-1493. doi: 10.1002/ijc.31532. Epub 2018 May 7.

11.

Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Robison NJ, Yeo KK, Berliner AP, Malvar J, Sheard MA, Margol AS, Seeger RC, Rushing T, Finlay JL, Sposto R, Dhall G.

J Neurooncol. 2018 May;138(1):199-207. doi: 10.1007/s11060-018-2791-y. Epub 2018 Feb 9.

12.

A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortium.

Sun W, Triche T Jr, Malvar J, Gaynon P, Sposto R, Yang X, Bittencourt H, Place AE, Messinger Y, Fraser C, Dalla-Pozza L, Salhia B, Jones P, Wayne AS, Gore L, Cooper TM, Liang G.

Blood. 2018 Mar 8;131(10):1145-1148. doi: 10.1182/blood-2017-09-803809. Epub 2018 Jan 16. No abstract available.

13.

Tumor-associated macrophages promote neuroblastoma via STAT3 phosphorylation and up-regulation of c-MYC.

Hadjidaniel MD, Muthugounder S, Hung LT, Sheard MA, Shirinbak S, Chan RY, Nakata R, Borriello L, Malvar J, Kennedy RJ, Iwakura H, Akamizu T, Sposto R, Shimada H, DeClerck YA, Asgharzadeh S.

Oncotarget. 2017 Sep 16;8(53):91516-91529. doi: 10.18632/oncotarget.21066. eCollection 2017 Oct 31.

14.

A prospective, observational cohort study comparing cancer clinical trial availability and enrollment between early adolescents/young adults and children.

Thomas SM, Malvar J, Tran H, Shows J, Freyer DR.

Cancer. 2018 Mar 1;124(5):983-990. doi: 10.1002/cncr.31127. Epub 2017 Nov 17.

15.

Marrow-ablative chemotherapy followed by tandem autologous hematopoietic cell transplantation in pediatric patients with malignant brain tumors.

Guerra JA, Dhall G, Marachelian A, Castillo E, Malvar J, Wong K, Sposto R, Finlay JL.

Bone Marrow Transplant. 2017 Nov;52(11):1543-1548. doi: 10.1038/bmt.2017.166. Epub 2017 Aug 7.

PMID:
28783147
16.

Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells.

Nakata R, Shimada H, Fernandez GE, Fanter R, Fabbri M, Malvar J, Zimmermann P, DeClerck YA.

J Extracell Vesicles. 2017 Jun 25;6(1):1332941. doi: 10.1080/20013078.2017.1332941. eCollection 2017.

17.

Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.

Borriello L, Nakata R, Sheard MA, Fernandez GE, Sposto R, Malvar J, Blavier L, Shimada H, Asgharzadeh S, Seeger RC, DeClerck YA.

Cancer Res. 2017 Sep 15;77(18):5142-5157. doi: 10.1158/0008-5472.CAN-16-2586. Epub 2017 Jul 7.

18.

Stir bar sorptive extraction and liquid chromatography-tandem mass spectrometry determination of polar and non-polar emerging and priority pollutants in environmental waters.

Aparicio I, Martín J, Santos JL, Malvar JL, Alonso E.

J Chromatogr A. 2017 Jun 2;1500:43-52. doi: 10.1016/j.chroma.2017.04.007. Epub 2017 Apr 7.

PMID:
28416215
19.

The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.

Ha VL, Luong A, Li F, Casero D, Malvar J, Kim YM, Bhatia R, Crooks GM, Parekh C.

Leukemia. 2017 Nov;31(11):2503-2514. doi: 10.1038/leu.2017.70. Epub 2017 Feb 24.

20.

Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.

Gupta S, Carmona R, Malvar J, Young G.

Thromb Res. 2017 Mar;151:44-50. doi: 10.1016/j.thromres.2016.09.017. Epub 2016 Sep 21.

PMID:
28110132
21.

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells.

Tran HC, Wan Z, Sheard MA, Sun J, Jackson JR, Malvar J, Xu Y, Wang L, Sposto R, Kim ES, Asgharzadeh S, Seeger RC.

Clin Cancer Res. 2017 Feb 1;23(3):804-813. doi: 10.1158/1078-0432.CCR-16-1743. Epub 2016 Oct 10.

22.

Treatment-related adverse events associated with a modified UK ALLR3 induction chemotherapy backbone for childhood relapsed/refractory acute lymphoblastic leukemia.

Sun W, Orgel E, Malvar J, Sposto R, Wilkes JJ, Gardner R, Tolbert VP, Smith A, Hur M, Hoffman J, Rheingold SR, Burke MJ, Wayne AS.

Pediatr Blood Cancer. 2016 Nov;63(11):1943-8. doi: 10.1002/pbc.26129. Epub 2016 Jul 20.

PMID:
27437864
23.

A parent-directed intervention for addressing academic risk in Latino survivors of childhood leukemia: results of a pilot study.

Bava L, Malvar J, Sposto R, Okada M, Gonzalez-Morkos B, Schweers LM, Nuñez C, Ruccione K, Katz ER, Freyer DR.

Psychooncology. 2016 Oct;25(10):1246-1249. doi: 10.1002/pon.4188. Epub 2016 Jul 4. No abstract available.

PMID:
27271226
24.

A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.

Cooper TM, Cassar J, Eckroth E, Malvar J, Sposto R, Gaynon P, Chang BH, Gore L, August K, Pollard JA, DuBois SG, Silverman LB, Oesterheld J, Gammon G, Magoon D, Annesley C, Brown PA.

Clin Cancer Res. 2016 Aug 15;22(16):4014-22. doi: 10.1158/1078-0432.CCR-15-1998. Epub 2016 Feb 26.

25.

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.

DuBois SG, Marachelian A, Fox E, Kudgus RA, Reid JM, Groshen S, Malvar J, Bagatell R, Wagner L, Maris JM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Czarnecki S, Tsao-Wei D, Matthay KK, Mosse YP.

J Clin Oncol. 2016 Apr 20;34(12):1368-75. doi: 10.1200/JCO.2015.65.4889. Epub 2016 Feb 16.

26.

Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.

Collins CL, Malvar J, Hamilton AS, Deapen DM, Freyer DR.

Cancer. 2015 Dec 15;121(24):4398-406. doi: 10.1002/cncr.29669. Epub 2015 Sep 22.

27.

Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy.

Malvar J, Vaida F, Sanders CF, Atkinson JH, Bohannon W, Keltner J, Robinson-Papp J, Simpson DM, Marra CM, Clifford DB, Gelman B, Fan J, Grant I, Ellis RJ; CHARTER Group.

Pain. 2015 Apr;156(4):731-9. doi: 10.1097/01.j.pain.0000461252.75089.bf.

28.

Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis.

HaDuong JH, Blavier L, Baniwal SK, Frenkel B, Malvar J, Punj V, Sposto R, DeClerck YA.

Int J Cancer. 2015 Aug 15;137(4):797-809. doi: 10.1002/ijc.29465. Epub 2015 Feb 21.

29.

Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia.

Orgel E, Tucci J, Alhushki W, Malvar J, Sposto R, Fu CH, Freyer DR, Abdel-Azim H, Mittelman SD.

Blood. 2014 Dec 18;124(26):3932-8. doi: 10.1182/blood-2014-08-595389. Epub 2014 Oct 27.

PMID:
25349177
30.

Characterization of transfusion-derived iron deposition in childhood cancer survivors.

Ruccione KS, Wood JC, Sposto R, Malvar J, Chen C, Freyer DR.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1913-9. doi: 10.1158/1055-9965.EPI-14-0292. Epub 2014 Jun 24.

31.

High dose alkylator therapy for extracranial malignant rhabdoid tumors in children.

Venkatramani R, Shoureshi P, Malvar J, Zhou S, Mascarenhas L.

Pediatr Blood Cancer. 2014 Aug;61(8):1357-61. doi: 10.1002/pbc.25093. Epub 2014 Apr 30.

PMID:
24789740
32.

Impact on survival and toxicity by duration of weight extremes during treatment for pediatric acute lymphoblastic leukemia: A report from the Children's Oncology Group.

Orgel E, Sposto R, Malvar J, Seibel NL, Ladas E, Gaynon PS, Freyer DR.

J Clin Oncol. 2014 May 1;32(13):1331-7. doi: 10.1200/JCO.2013.52.6962. Epub 2014 Mar 31.

33.

Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation.

De A, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Mascarenhas L, Keens TG, Venkatramani R.

Pediatr Pulmonol. 2015 Jun;50(6):596-603. doi: 10.1002/ppul.23034. Epub 2014 Mar 18.

PMID:
24644268
34.

Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation.

Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L.

Pediatr Blood Cancer. 2014 Jul;61(7):1277-81. doi: 10.1002/pbc.24969. Epub 2014 Jan 31.

PMID:
24482138
35.

PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas.

Erdreich-Epstein A, Robison N, Ren X, Zhou H, Xu J, Davidson TB, Schur M, Gilles FH, Ji L, Malvar J, Shackleford GM, Margol AS, Krieger MD, Judkins AR, Jones DT, Pfister SM, Kool M, Sposto R, Asgharzadeh S.

Clin Cancer Res. 2014 Feb 15;20(4):827-36. doi: 10.1158/1078-0432.CCR-13-2053. Epub 2013 Dec 3. Erratum in: Clin Cancer Res. 2015 Sep 15;21(18):4243. Asgharazadeh, Shahab [corrected to Asgharzadeh, Shahab].

36.

A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

Raetz EA, Morrison D, Romanos-Sirakis E, Gaynon P, Sposto R, Bhojwani D, Bostrom BC, Brown P, Eckroth E, Cassar J, Malvar J, Buchbinder A, Carroll WL.

J Pediatr Hematol Oncol. 2014 Aug;36(6):458-63. doi: 10.1097/MPH.0b013e3182a8f58f.

37.

Adipocyte differentiation is affected by media height above the cell layer.

Sheng X, Tucci J, Malvar J, Mittelman SD.

Int J Obes (Lond). 2014 Feb;38(2):315-20. doi: 10.1038/ijo.2013.96. Epub 2013 Jun 7.

38.

Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation.

Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):942-8. doi: 10.1016/j.ijrobp.2013.04.037. Epub 2013 May 29.

PMID:
23726005
39.

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.

Messinger YH, Gaynon PS, Sposto R, van der Giessen J, Eckroth E, Malvar J, Bostrom BC; Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium.

Blood. 2012 Jul 12;120(2):285-90. doi: 10.1182/blood-2012-04-418640. Epub 2012 May 31.

PMID:
22653976
40.

Novel pathways to erythropoiesis induced by dimerization of intracellular C-Mpl in human hematopoietic progenitors.

Parekh C, Sahaghian A, Kim W, Scholes J, Ge S, Zhu Y, Asgharzadeh S, Hollis R, Kohn D, Ji L, Malvar J, Wang X, Crooks G.

Stem Cells. 2012 Apr;30(4):697-708. doi: 10.1002/stem.1046.

41.

Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.

Venkatramani R, Wang L, Malvar J, Dias D, Sposto R, Malogolowkin MH, Mascarenhas L.

Pediatr Blood Cancer. 2012 Sep;59(3):493-8. doi: 10.1002/pbc.24038. Epub 2011 Dec 20.

PMID:
22190448
42.

Early effects of lipopolysaccharide-induced inflammation on foetal brain development in rat.

Ghiani CA, Mattan NS, Nobuta H, Malvar JS, Boles J, Ross MG, Waschek JA, Carpenter EM, Fisher RS, de Vellis J.

ASN Neuro. 2011 Nov 17;3(4). pii: e00068. doi: 10.1042/AN20110027.

43.

The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth.

Ghiani CA, Starcevic M, Rodriguez-Fernandez IA, Nazarian R, Cheli VT, Chan LN, Malvar JS, de Vellis J, Sabatti C, Dell'Angelica EC.

Mol Psychiatry. 2010 Feb;15(2):115, 204-15. doi: 10.1038/mp.2009.58. Epub 2009 Jun 23.

44.

Genetic program of neuronal differentiation and growth induced by specific activation of NMDA receptors.

Ghiani CA, Beltran-Parrazal L, Sforza DM, Malvar JS, Seksenyan A, Cole R, Smith DJ, Charles A, Ferchmin PA, de Vellis J.

Neurochem Res. 2007 Feb;32(2):363-76. Epub 2006 Dec 27.

PMID:
17191130
45.

Gene expression is differentially regulated by neurotransmitters in embryonic neuronal cortical culture.

Ghiani CA, Lelievre V, Beltran-Parrazal L, Sforza DM, Malvar J, Smith DJ, Charles AC, Ferchmin PA, de Vellis J.

J Neurochem. 2006 Apr;97 Suppl 1:35-43.

Supplemental Content

Loading ...
Support Center